Information updates

Launch of National Allergy Council and National Allergy Centre of Excellence

In a major step towards addressing Australia’s allergy epidemic, the Hon. Ged Kearney MP, Assistant Minister for Health and Aged Care, alongside allergy experts, has launched two world-first allergy organisations at a media event on Wednesday 31st August 2022 in Melbourne, during the ASCIA 2022 Conference week.

The new National Allergy Council and National Allergy Centre of Excellence are backed by a $26.9 million Federal Government investment, and will address recommendations from the Walking the allergy tightrope report from the Parliamentary Inquiry into allergies and anaphylaxis:

  • The National Allergy Council (NAC) is a natural progression of the highly valued and successful National Allergy Strategy. The NAC will continue to implement and expand the National Allergy Strategy as a partnership between the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia (A&AA) – the leading medical and patient support organisations for allergy in Australia.
  • The Centre for Food & Allergy Research (CFAR), hosted at the Murdoch Children’s Research Institute, has expanded to become the National Allergy Centre of Excellence (NACE). As Australia’s peak allergy research body, it will develop hubs for allergy research, repository and discovery, evidence and translation, and training and innovation. This will ensure Australia remains at the forefront of evidence-based management of allergic disease.
  • The NAC and NACE, with support from the country’s peak allergy organisations encompassing clinicians, researchers, policy-makers, patients and carers, look forward to working together to ensure efficient translation of the latest research into practice.

These initiatives will help accelerate allergy research and clinical care, to improve the lives of five million Australians living with allergic disease and prevent anaphylaxis, including needless deaths.

Read the Media Release here

This news item was issued on 31 August 2022 and updated on 12 September by Jill Smith, CEO of the Australasian Society of Clinical Immunology and Allergy (ASCIA). ASCIA is the peak professional body for clinical immunology and allergy in Australia and New Zealand.   

Mod ASCIA Member
Donate to AIFA
go to NAC website
ASCIA Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:

About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

healthdirect